Published in Int J Circumpolar Health on February 01, 2005
Serotyping of Streptococcus pneumoniae isolates from nasopharyngeal samples: use of an algorithm combining microbiologic, serologic, and sequential multiplex PCR techniques. J Clin Microbiol (2011) 1.02
Otitis media and the epidemiologic triangle. Int J Circumpolar Health (2005) 0.80
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann Intern Med (2003) 4.65
Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis (2004) 3.31
Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med (2005) 3.18
Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med (2003) 2.87
Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis (2004) 2.42
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology (2007) 2.34
An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol (2003) 2.31
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis (2006) 2.30
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis (2006) 2.23
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial. Pediatr Infect Dis J (2013) 1.84
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis (2009) 1.66
Endemic foodborne botulism among Alaska Native persons--Alaska, 1947-2007. Clin Infect Dis (2011) 1.66
Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J (2008) 1.50
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis (2004) 1.43
Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Clin Infect Dis (2005) 1.40
International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Emerg Infect Dis (2008) 1.34
Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine (2007) 1.33
Potential impacts of climate change on infectious diseases in the Arctic. Int J Circumpolar Health (2005) 1.33
Outbreak of invasive Haemophilus influenzae serotype a disease. Pediatr Infect Dis J (2005) 1.31
Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology (2011) 1.29
The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics (2006) 1.27
Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska. Clin Infect Dis (2002) 1.25
Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology (2004) 1.25
Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg Infect Dis (2008) 1.19
Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season. Pediatr Infect Dis J (2006) 1.19
Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J (2005) 1.19
Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J (2004) 1.17
Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis (2008) 1.16
2009 Pandemic influenza A H1N1 in Alaska: temporal and geographic characteristics of spread and increased risk of hospitalization among Alaska Native and Asian/Pacific Islander people. Clin Infect Dis (2011) 1.14
Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Pediatr Infect Dis J (2007) 1.14
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska native adults. Vaccine (2006) 1.10
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. Vaccine (2002) 1.09
Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Pediatrics (2003) 1.09
Innovative primary care delivery in rural Alaska: a review of patient encounters seen by community health aides. Int J Circumpolar Health (2012) 1.08
Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis (2009) 1.07
Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--Alaska, 2008-2012. J Infect Dis (2013) 1.07
The effect of antimicrobial use on nasopharyngeal colonization by Streptococcus pneumoniae and Haemophilus influenzae. Pediatr Infect Dis J (2014) 1.06
The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clin Infect Dis (2006) 1.06
Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. Hum Vaccin (2006) 1.05
Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age. Clin Infect Dis (2009) 1.05
Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection. Gastroenterology (2009) 1.04
Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. Clin Infect Dis (2003) 1.00
Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol (2004) 0.98
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter (2006) 0.98
Diabetes prevalence, incidence, complications and mortality among Alaska Native people 1985-2006. Int J Circumpolar Health (2010) 0.97
Risk factors for hospitalization with lower respiratory tract infections in children in rural Alaska. Pediatrics (2012) 0.97
Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J (2003) 0.96
Call-tracking data and the public health response to bioterrorism-related anthrax. Emerg Infect Dis (2002) 0.95
Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C. Can J Gastroenterol (2010) 0.93
Infectious disease hospitalizations among older American Indian and Alaska Native adults. Public Health Rep (2007) 0.92
Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies. Clin Diagn Lab Immunol (2005) 0.92
Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population. World J Gastroenterol (2011) 0.91
Assessment of carriage of Haemophilus influenzae type a after a case of invasive disease. Clin Infect Dis (2006) 0.90
Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up. Hepatology (2012) 0.90
Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness. Vaccine (2011) 0.90
Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera. Am J Gastroenterol (2004) 0.89
Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series. J Infect Dis (2012) 0.88
Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine. Pediatr Infect Dis J (2002) 0.88
Alaska sentinel surveillance study of Helicobacter pylori isolates from Alaska Native persons from 2000 to 2008. J Clin Microbiol (2011) 0.88
MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006. Emerg Infect Dis (2012) 0.86
The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations. Vaccine (2011) 0.86
Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska. Vaccine (2010) 0.86
Increasing trend in the rate of infectious disease hospitalisations among Alaska Native people. Int J Circumpolar Health (2013) 0.86
Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults. Vaccine (2003) 0.85